Delivery Order SPE2DB20D1004-SPE2DB21FG0P6
- Not listed
- This federal contract award, valued at $3,739.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,556,276,963 units of PRADAXA 150 MG CAPSULE with a completion date of February 16, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.94 firm-fixed price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The contract has an ultimate completion date of October 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pradaxa 150 mg capsules. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,095.18 firm fixed-price delivery order is for the supply of 150 mg PRADAXA capsules, a medication used to treat cardiovascular conditions. The contract has a period of performance through December 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award is for the delivery of the pharmaceutical product PRADAXA 150 MG CAPSULE UU 60S to the Defense Logistics Agency (DLA). The $5,673.10 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of December 14, 2021 and was awarded on December 13, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PRADAXA 150 MG capsules. The contract, a Delivery Order worth $4,725.52, was awarded on November 8, 2022 with a completion date of November 9, 2022. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,804.15 firm fixed-price delivery order contract is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,947.96, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a period of performance through March 6, 2023. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,018.15 firm fixed price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract has an ultimate completion date of April 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.58 firm-fixed-price delivery order is for the provision of 4,561,171,138 units of the prescription medication PRADAXA 150 mg capsules. The contract has a performance period through June 8, 2023 and was awarded on June 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FG0P6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,756,127 units of the drug PRADAXA 150 MG CAPSULE. The contract has a firm fixed price ceiling value of $1,334.33 and an ultimate completion date of September 14, 2021. The contract is a delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/13/21 |